Adjuvant Chemotherapy In Gastric Cancer Quito-Ecuador
Artículo
| IMSEAR
| ID: sea-184919
ABSTRACT
OBJECTIVE:
To determine the overall survival time in patients treated with adjuvant chemoradiotherapy.METHODS:
Retrospectivestudyofpatientswithadiagnosisofgastricadenocarcinomaor gastroesophageal junction who received adjuvant chemoradiotherapy treatment during the years 2011 to 2015.RESULTS:
We analized 197 subjects of which 115 were men (58.4%) and 82 women (41.6%) were included in the analysis; between the ages of 18 and 89 years old, distributed in clinical stages IB to IIIC, showing a general average survival of 51.5 months with a Log Rank of 2.98; 95% CI (45.7 - 57.4) with a general survival of up to 90 months.CONCLUSION:
The study showed a greater overall survival than the data reported in the Intergroup 0116 and ARTIST study.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
País/Región como asunto:
America del Sur
/
Ecuador
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS